Loading Rate of Exogenous and Autoantigenic Determinants on Major Histocompatibility Complex Class II Mediates Resistance to Multiple Sclerosis
- Autores: Mamedov A.E.1, Zakharova M.Y.1,2, Favorova O.O.2, Kulakova O.G.2, Boyko A.N.2, Knorre V.D.1, Vorobieva N.A.3, Khurs E.N.4, Kiselev I.S.2, Baulina N.M.2, Gabibov A.G.1,5, Belogurov A.A.1,5
-
Afiliações:
- Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
- Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
- Institute of Gene Biology, Russian Academy of Sciences
- Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
- Biological Faculty, Moscow State University
- Edição: Volume 485, Nº 1 (2019)
- Páginas: 115-118
- Seção: Biochemistry, Biophysics, and Molecular Biology
- URL: https://journals.rcsi.science/1607-6729/article/view/212897
- DOI: https://doi.org/10.1134/S1607672919020078
- ID: 212897
Citar
Resumo
Genetic analysis of thousands of patients with multiple sclerosis (MS) and healthy Russian donors showed that the carriage of groups of HLA-DRB1*15 and HLA-DRB1*03 alleles is associated with the risk of MS, whereas the carriage of groups of HLA-DRB1*01 and HLA-DRB1*11 alleles is protective. Recombinant HLA-DRB1*01:01 with a high affinity can recognize the fragments of myelin basic protein (MBP), one of the autoantigens in MS. However, the comparison of the kinetic parameters of the load of MBP and viral HA peptides on HLA-DRB1*01:01, which is catalyzed by HLA-DM, showed a significantly lower rate of exchange of CLIP for MBP peptides. We assume that the observed protective properties of the group of HLA-DRB1*01 alleles may be directly associated with the ability of HLA-DRB1*01:01 to kinetically distinguish peptides of exogenous and endogenous nature.
Sobre autores
A. Mamedov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Autor responsável pela correspondência
Email: bioaz12@gmail.com
Rússia, Moscow, 117997
M. Zakharova
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997; Moscow, 117997
O. Favorova
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997
O. Kulakova
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997
A. Boyko
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997
V. Knorre
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences
Autor responsável pela correspondência
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997
N. Vorobieva
Institute of Gene Biology, Russian Academy of Sciences
Email: vera.knorre@gmail.com
Rússia, Moscow, 119334
E. Khurs
Engelhardt Institute of Molecular Biology, Russian Academy of Sciences
Email: vera.knorre@gmail.com
Rússia, Moscow, 119991
I. Kiselev
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997
N. Baulina
Pirogov Russian National Research Medical University, Ministry of Healthcare of the Russian Federation
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997
A. Gabibov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Biological Faculty, Moscow State University
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997; Moscow, 119234
A. Belogurov
Shemyakin–Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences; Biological Faculty, Moscow State University
Email: vera.knorre@gmail.com
Rússia, Moscow, 117997; Moscow, 119234
Arquivos suplementares
